GSA Capital Partners’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16K | Sell |
14,142
-20,530
| -59% | -$23.2K | ﹤0.01% | 1693 |
|
|
2025
Q1 | $47K | Buy |
+34,672
| New | +$47K | ﹤0.01% | 1551 |
|
|
2023
Q4 | – | Sell |
-45,587
| Closed | -$790K | – | 1823 |
|
|
2023
Q3 | $790K | Buy |
+45,587
| New | +$790K | 0.07% | 525 |
|
|
2023
Q2 | – | Sell |
-19,206
| Closed | -$511K | – | 1849 |
|
|
2023
Q1 | $511K | Sell |
19,206
-1,053
| -5% | -$28K | 0.05% | 706 |
|
|
2022
Q4 | $392K | Sell |
20,259
-1,976
| -9% | -$38.2K | 0.05% | 756 |
|
|
2022
Q3 | $464K | Sell |
22,235
-50,818
| -70% | -$1.06M | 0.06% | 626 |
|
|
2022
Q2 | $585K | Buy |
73,053
+4,817
| +7% | +$38.6K | 0.09% | 399 |
|
|
2022
Q1 | $478K | Buy |
68,236
+9,643
| +16% | +$67.6K | 0.06% | 559 |
|
|
2021
Q4 | $791K | Buy |
58,593
+32,726
| +127% | +$442K | 0.1% | 320 |
|
|
2021
Q3 | $437K | Buy |
+25,867
| New | +$437K | 0.04% | 779 |
|